Výsledky vyhledávání - Ming‐Shyang Huang
- Zobrazuji výsledky 1 - 3 z 3
-
1
Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells Autor An-Fu Lee, Man‐Chin Chen, Chao‐Ju Chen, Chih‐Jen Yang, Ming‐Shyang Huang, Yu‐Peng Liu
Vydáno 2017Artigo -
2
<scp>PCAF</scp>‐mediated acetylation of <scp>ISX</scp> recruits <scp>BRD</scp>4 to promote epithelial‐mesenchymal transition Autor Li‐Ting Wang, Kwei‐Yan Liu, W.Y. Jeng, Cheng‐Ming Chiang, Chee‐Yin Chai, Shyh‐Shin Chiou, Ming‐Shyang Huang, Kazunari K. Yokoyama, Shen‐Nien Wang, Shau‐Ku Huang, Shih‐Hsien Hsu
Vydáno 2020Artigo -
3
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients... Autor Shih-Lung Cheng, Ming-Lin Ho, Yun-Fa Lai, Hao‐Chien Wang, Jeng‐Yuan Hsu, Shih‐Feng Liu, Ming-Shyang Huang, Cheng-Hung Lee, Ching‐Hsiung Lin, Liang‐Wen Hang, Yu‐Chih Liu, Kuang‐Yao Yang, Jia-Horng Wang
Vydáno 2021Errata/Corrigenda
Vyhledávací nástroje:
Související témata
Biology
Cancer
Cancer research
Epithelial–mesenchymal transition
Internal medicine
Medicine
Metastasis
Acetylation
Anesthesia
Asthma
BRD4
Bromodomain
Budesonide
Cell biology
Chemistry
Chromatin
Ectopic expression
Epidermal growth factor receptor
Epigenetics
Erlotinib
Fluticasone
Fluticasone propionate
Formoterol
Formoterol Fumarate
Gefitinib
Gene
Genetics
Histone
Lung cancer
Oncology